Triple immunofluorescence staining showed limited co-expression of PDPN and PD-L1 in benign nevi, whereas marked upregulation and co-expression were observed in primary (e.g., #3, #22) and metastatic (e.g., #110) melanoma lesions (Figure 2A). This evidence concerns the gene PDPN and melanoma.